Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adamed is a leading Polish pharmaceutical and biotechnology company that integrates research, development, and manufacturing of high-quality medicinal products. The company maintains a diverse portfolio encompassing prescription drugs, over-the-counter (OTC) medicines, and dietary supplements across therapeutic areas like cardiology, psychiatry, and gynecology. Adamed is recognized for its commitment to innovation, investing significantly in the development of value-added medicines and original drug candidates. With multiple production facilities and a growing international footprint, the company serves patients in dozens of countries worldwide. Its research efforts focus on oncology and central nervous system disorders, utilizing advanced chemical and biological platforms. Adamed remains a family-owned enterprise, emphasizing long-term growth and sustainable healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adamed Consumer Healthcare.